Mochi Health reviews and lawsuit 2026: what it costs, what the public record shows, and where the case stands

Short answer

Mochi Health Corp. is a San Francisco telehealth company. It provides administrative services to affiliated medical practices, including Mochi Medical, P.A. (Florida), Mochi Medical CA, P.C. and Mochi Medical KS, P.A., whose clinicians prescribe. Mochi charges two things: a membership and, separately, the medication. On November 3, 2026, membership was $79 a month or $588 for 12 months, and Mochi listed compounded semaglutide from $60 a month and compounded tirzepatide from $90 a month, priced by dose. Its public record: a 4.5 TrustScore from 19,945 Trustpilot reviews, and a BBB profile marked "under review" with no rating shown. Eli Lilly sued Mochi Health in federal court in 2025; parts of the case have been dismissed and parts continue. We found no FDA warning letter addressed to Mochi. Mochi is not scored or ranked in this guide.

Is Mochi Health legit?

Mochi is an operating company with a defined legal structure. Three separate questions decide whether it suits you.

• Who prescribes. Mochi’s terms say clinicians work for affiliated professional practices, including Mochi Medical, P.A., Mochi Medical CA, P.C. and Mochi Medical KS, P.A. Mochi Health Corp. itself does not provide medical care.
• Who dispenses. Mochi runs a pharmacy marketplace: partner pharmacies list their medications, and its FAQ says medication pricing varies by pharmacy. The pages we read do not name the pharmacy that fills compounded GLP-1 orders. Ask before you pay, and check that pharmacy’s license with its state board of pharmacy.
• Whether there is legal action. Eli Lilly’s lawsuit is covered below. A lawsuit sets out allegations; it is not a finding against the company.

Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness or quality before they are sold.

What Mochi Health costs

At the lowest listed dose prices, a month on the 1-month plan comes to $169 for compounded tirzepatide ($79 plus $90) or $139 for compounded semaglutide ($79 plus $60). The medication price rises with the dose, and Mochi does not publish the higher-dose prices, so ask for your dose and price in writing before you pay.

The Eli Lilly lawsuit: what the court record shows

Case: Eli Lilly and Company v. Mochi Health Corp., et al., No. 3:25-cv-03534, U.S. District Court for the Northern District of California, assigned to Judge Jacqueline Scott Corley. Filed in April 2025.

• What Lilly alleges. Lilly alleges Mochi Health sold compounded tirzepatide in a way that misled consumers and amounted to unfair competition. Its amended complaint alleges Mochi Health controls medical decisions at its affiliated practices, which California law reserves to licensed doctors, and that Mochi changed compounded doses for business reasons. Mochi Health has moved to dismiss the claims. These are allegations; no court has found them true.
• 2025. The court granted Mochi Health’s first motion to dismiss, finding Lilly had not shown how it was harmed, and allowed Lilly to amend.
• April 2026. The court partly denied Mochi Health’s second motion to dismiss and let Lilly proceed on claims under California’s Unfair Competition Law and the federal Lanham Act. Source: Courthouse News, April 21, 2026.
• September 8, 2026. The court further narrowed the case. It found Lilly had not plausibly alleged that the Mochi Medical practices or Aequita Pharmacy conspired to violate the Lanham Act, and let California unfair competition claims against Aequita Pharmacy and its parent company proceed. Source: Courthouse News, September 8, 2026.
• Status on November 3, 2026: the case is open. No trial has taken place and there is no judgment.

Read the reporting: Courthouse News, April 21, 2026 (opens in a new tab) and Courthouse News, September 8, 2026 (opens in a new tab).

Other federal cases naming Mochi (docket facts only)

• Ward v. Mochi Health Corp., No. 3:26-cv-01393 (N.D. Cal.), filed February 17, 2026. The docket lists the nature of suit as "Civil Rights: Other." Open; last filing October 30, 2026. Docket: Ward v. Mochi Health Corp. (opens in a new tab).
• Cioppettini v. Mochi Medical CA, P.C., No. 4:26-cv-01260 (N.D. Cal.), filed February 11, 2026, under the Fair Labor Standards Act (an employment-pay claim, not a patient claim). Docket: Cioppettini v. Mochi Medical CA, P.C. (opens in a new tab).

A filed case records what one side claims. Read the docket for the current status before drawing conclusions.

Reviews and complaints, by the numbers

A star rating measures customer experience, not medical quality. Mochi’s BBB profile showed no rating while under review; check it again before you rely on it.

How to cancel Mochi Health, and what you get back

From Mochi’s terms and conditions (updated September 22, 2026) and refund policy, read November 3, 2026:

• Cancel the membership at any time in your Mochi account ("cancel subscription") or by phone at (619) 648-1247.
• The membership continues to the end of the term you paid for and then does not renew. Cancelling the membership also cancels medication subscriptions that need an active membership.
• Cancel or change a medication subscription before a refill request goes to the pharmacy, using "Modify" on the medication page.
• No refunds for partly used subscription periods, except case by case at Mochi’s discretion. Medication fees are not refundable once an order is sent to a pharmacy, and all prescription sales are final.
• Disputes go to binding individual arbitration with a class-action waiver. You can opt out within 30 days of first accepting the terms by emailing [email protected].

Questions to ask before you pay

• What will my medication cost at each dose step, in writing?
• Which pharmacy will fill my prescription, and in which state is it licensed?
• If I prepay a 6- or 12-month membership, what happens to the remaining months if I stop?
• When does each refill request go to the pharmacy, so I know my cancellation cutoff?

Compare before you choose

• Membership vs bundled pricing
• GLP-1 cancellation policies compared
• What tirzepatide costs
• MEDVi reviews 2026

Frequently asked questions